Clinical Trial Update: Extended-release Naltrexone for Alcohol Dependence in Primary Care [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating extended-release naltrexone for alcohol dependence in primary care completed. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: NYU Langone Health | Conditions: Alcohol Dependence | Phase 4 | Status: COMPLETED | Results posted: 2011-09-27